Viewing Study NCT00274651


Ignite Creation Date: 2025-12-24 @ 11:39 PM
Ignite Modification Date: 2026-02-10 @ 8:37 AM
Study NCT ID: NCT00274651
Status: TERMINATED
Last Update Posted: 2015-07-28
First Post: 2006-01-10
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Phase II Clinical Trial of PXD101 in Patients With Recurrent or Refractory Cutaneous and Peripheral T-Cell Lymphomas
Sponsor: Valerio Therapeutics
Organization: